by Steve Adams | Nov 10, 2023
In a direct contrast to the office market, where tenants have gravitated to new high-end buildings for lease commitments since 2020, life science developers are finding muted demand for the new crop of lab buildings dotting the local landscape.
by Steve Adams | Jan 11, 2023
Greater Boston’s once-burgeoning lab market took a step back in the fourth quarter, as sublease space hit 1.5 million square feet.
by Steve Adams | Sep 25, 2022
Life science brokers like Molly Heath are adjusting to new market fundamentals as they help match biotechs with space availabilities even as the industry’s rapid growth in the last two years cools.
by Steve Adams | Sep 4, 2022
Sublease availabilities more than doubled in the second quarter to 916,000 square feet, but commercial developers continue to play the lab card as their best bet for virtually every development site.
by Steve Adams | Aug 9, 2022
Biogen is offering over 263,000 square feet of office and research space in Cambridge and Weston for sublease in the latest retrenchment of the life science industry’s local footprint.